- Home
- LIXT vs WKSP Comparison
LIXT vs WKSP Comparison
Compare LIXT & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- WKSP
- Stock Information
- Founded
- LIXT 2005
- WKSP 2003
- Country
- LIXT United States
- WKSP United States
- Employees
- LIXT N/A
- WKSP N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- LIXT Health Care
- WKSP Consumer Discretionary
- Exchange
- LIXT Nasdaq
- WKSP Nasdaq
- Market Cap
- LIXT 20.5M
- WKSP 17.2M
- IPO Year
- LIXT N/A
- WKSP N/A
- Fundamental
- Price
- LIXT $4.00
- WKSP $2.27
- Analyst Decision
- LIXT
- WKSP Strong Buy
- Analyst Count
- LIXT 0
- WKSP 3
- Target Price
- LIXT N/A
- WKSP $12.83
- AVG Volume (30 Days)
- LIXT 86.0K
- WKSP 244.5K
- Earning Date
- LIXT 11-12-2025
- WKSP 11-13-2025
- Dividend Yield
- LIXT N/A
- WKSP N/A
- EPS Growth
- LIXT N/A
- WKSP N/A
- EPS
- LIXT N/A
- WKSP N/A
- Revenue
- LIXT N/A
- WKSP $14,286,679.00
- Revenue This Year
- LIXT N/A
- WKSP $148.41
- Revenue Next Year
- LIXT N/A
- WKSP $88.10
- P/E Ratio
- LIXT N/A
- WKSP N/A
- Revenue Growth
- LIXT N/A
- WKSP 123.37
- 52 Week Low
- LIXT $0.64
- WKSP $1.92
- 52 Week High
- LIXT $6.26
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- LIXT 41.53
- WKSP 38.77
- Support Level
- LIXT $4.14
- WKSP $1.95
- Resistance Level
- LIXT $4.49
- WKSP $2.25
- Average True Range (ATR)
- LIXT 0.42
- WKSP 0.26
- MACD
- LIXT 0.00
- WKSP -0.01
- Stochastic Oscillator
- LIXT 34.03
- WKSP 32.32
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.